Key result
Implantable VAD bridging enables successful hospital discharge in prolonged post-AMI cardiogenic shock with multiorgan failure.
Why the study?
Management strategies for prolonged cardiogenic shock with multiorgan failure after acute myocardial infarction requiring transition from extracorporeal to implantable ventricular assist devices are not well established.
Case Report (n=1)
No
Transitioning from an extracorporeal to an implantable ventricular assist device can be a successful bridge-to-transplant strategy for young patients with refractory cardiogenic shock and multiple organ failure following acute myocardial infarction.
Supports staged VAD transition in select young AMI shock cases; hypothesis-generating, requires prospective validation before broader adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Murata et al. (2019) conducted a case report in Acute myocardial infarction with cardiogenic shock and multiple organ failure (n=1). Ventricular assist device (e-VAD followed by i-VAD) was evaluated on Clinical course and survival. A 28-year-old man with prolonged cardiogenic shock and multiple organ failure following acute myocardial infarction was successfully bridged to an implantable ventricular assist device and discharged home.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: